Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-29

FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc. The action indicates an update to the drug…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viread (tenofovir disoproxil fumarate)

Snippet

SUPPL AP for VIREAD (TENOFOVIR DISOPROXIL FUMARATE)